Page last updated: 2024-11-01

ondansetron and Blindness

ondansetron has been researched along with Blindness in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research Excerpts

ExcerptRelevanceReference
"Progressive encephalopathy and partial loss of vision were the main observed signs."2.39Subacute encephalopathic toxicity of cisplatin. ( Conrad, CA; Hong, WK; Verschraegen, C, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perry, JD1
Cherian, A1
Maguire, M1
Verschraegen, C1
Conrad, CA1
Hong, WK1

Reviews

1 review available for ondansetron and Blindness

ArticleYear
Subacute encephalopathic toxicity of cisplatin.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Diseases; Ci

1995

Other Studies

2 other studies available for ondansetron and Blindness

ArticleYear
Letter to the editor regarding article, "A challenging problem that concerns the aesthetic surgeon".
    Annals of plastic surgery, 2009, Volume: 62, Issue:6

    Topics: Antiemetics; Blindness; Eye Hemorrhage; Humans; Ondansetron; Postoperative Nausea and Vomiting

2009
Transient blindness following intravenous ondansetron.
    Anaesthesia, 2005, Volume: 60, Issue:9

    Topics: Adult; Antiemetics; Blindness; Female; Humans; Ondansetron; Postoperative Complications; Postoperati

2005